May 22, 2020 / 9:51 AM / 13 days ago

BRIEF-Oxford, Astra Covid Vaccine Candidate To Move To Phase II/III Human Trials

May 22 (Reuters) - University of Oxford:

* OXFORD UNIVERSITY, ASTRAZENECA START PHASE II/III HUMAN TRIALS FOR EXPERIMENTAL COVID-19 VACCINE

* NEXT STUDY ON COVID-19 VACCINE TO ENROL UP TO 10,260 ADULTS & CHILDREN; TO INVOLVE NUMBER OF PARTNER INSTITUTIONS ACROSS COUNTRY

* PHASE III PART OF COVID-19 VACCINE STUDY INVOLVES ASSESSING HOW VACCINE WORKS IN LARGE NUMBER OF PEOPLE OVER THE AGE OF 18 Source text: [ID:bit.ly/3bVGlKG] Further company coverage: (AZN.L)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below